SI
ABBV icon

Seeds Investor’s AbbVie ABBV Stock Holding History

Seeds Investor’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.02M Sell
4,040
-721
-15% -$155K 0.1% 146
2026
Q1 		$1M Buy
4,761
+39
+0.8% +$8.65K 0.14% 122
2025
Q4 		$1.08M Buy
4,722
+3,115
+194% +$710K 0.21% 79
2025
Q3 		$372K Buy
1,607
+9
+0.6% +$1.83K 0.08% 155
2025
Q2 		$297K Sell
1,598
-44
-3% -$8.18K 0.07% 180
2025
Q1 		$344K Sell
1,642
-322
-16% -$62.6K 0.1% 151
2024
Q4 		$349K Sell
1,964
-97
-5% -$17.8K 0.1% 150
2024
Q3 		$407K Buy
+2,061
New +$385K 0.15% 121

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Seeds Investor's ABBV Position: Q2 2026 in Review

Seeds Investor reduced its AbbVie (ABBV) stake by 15% in Q2 2026, selling an estimated $155K and leaving 4,040 shares worth $1.02M. The position accounts for 0.1% of the portfolio, ranked #146.

Seeds Investor first reported a position in ABBV in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.08M in Q4 2025. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Seeds Investor held 4,040 shares of AbbVie worth $1.02M as of Q2 2026.
  • Seeds Investor sold 721 AbbVie shares in Q2 2026, an estimated $155K.
  • AbbVie made up 0.1% of Seeds Investor's portfolio in Q2 2026, its #146 holding.
  • Seeds Investor first reported a position in AbbVie in Q3 2024 and has held it in 8 quarters since.
  • Seeds Investor's AbbVie position peaked at $1.08M in Q4 2025.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Seeds Investor's 13F filing for Q2 2026, filed 12 Aug 2026.